Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
168 studies found for:    new onset type 1 diabetes
Show Display Options
Rank Status Study
21 Completed
Has Results
Rituximab in New Onset Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Anti-CD20 (rituximab);   Drug: Placebo Comparator
22 Withdrawn The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Omeprazole for Insulin Independence Among Recent Onset Type 1 Diabetes Patients
Condition: Type 1 Diabetes
Interventions: Drug: Oral Cyclosporine and Oral Omeprazole;   Drug: Oral Omeprazole
23 Enrolling by invitation Effects of Gluten Free Diet on Type 1 Diabetes Mellitus in Children
Condition: Type 1 Diabetes Mellitus
Interventions: Other: Gluten Free Diet;   Other: Placebo
24 Completed Anti-Interleukin-1 in Diabetes Action
Condition: Type 1 Diabetes
Interventions: Drug: anakinra;   Drug: saline
25 Terminated
Has Results
A Research Trial of Aralast in New Onset Diabetes (RETAIN)
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Aralast NP 45 mg dose;   Biological: Aralast NP 90 mg dose;   Biological: Aralast NP 180 mg dose
26 Active, not recruiting Pilot Clinical Trial of Ustekinumab in Patients With New-onset T1D
Condition: Type 1 Diabetes
Intervention: Drug: Ustekinumab
27 Completed Etanercept in New Onset Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Etanercept;   Drug: Placebo
28 Recruiting Tauroursodeoxycholic Acid (TUDCA) in New-Onset Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Tauroursodeoxycholic Acid (TUDCA);   Drug: Sugar Pill (placebo)
29 Completed Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Otelixizumab;   Biological: Placebo
30 Completed
Has Results
Atorvastatin in New Onset Type 1 Diabetes Mellitus (T1DM)
Condition: Type 1 Diabetes
Interventions: Drug: Atorvastatin;   Other: Placebo
31 Withdrawn A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part II
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Aralast NP;   Drug: Placebo
32 Active, not recruiting Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type I;   Diabetes Mellitus, Insulin-Dependent, 1;   Type 1 Diabetes Mellitus;   Insulin-Dependent Diabetes Mellitus 1;   IDDM
Interventions: Drug: Imatinib Mesylate;   Drug: Placebo (For imatinib mesylate)
33 Recruiting The Effect of Gluten-free Diet on New Onset Type 1 Diabetes (T1D)
Condition: Type 1 Diabetes
Intervention: Other: Gluten-free diet
34 Withdrawn A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52 Antibody) Therapy in Newly Diagnosed Subjects With Type 1 Diabetes Mellitus
Condition: New Onset Type 1 Diabetes Mellitus
Intervention: Drug: Campath 1H® (Alemtuzumab)
35 Completed A Study of Two Versus Three Daily Injections in Children and Adolescents With Newly Diagnosed Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Twice Daily versus Three Times Daily Insulin Injections
36 Completed
Has Results
Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Anti-CD3 mAb;   Other: Diabetes Standard of Care Treatment;   Dietary Supplement: Iron supplementation
37 Terminated
Has Results
Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Secukinumab;   Drug: Placebo
38 Completed Safety Study to Assess Whether Proinsulin Peptide Injections Can Slow or Stop the Body Damaging Its Own Insulin-making Cells in the Pancreas in Patients Newly Diagnosed With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Pro insulin peptide;   Drug: Saline
39 Recruiting Minimal Islet Transplant at Diabetes Onset
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Human pancreatic islet;   Drug: ATG;   Drug: Pegylated G-CSF;   Drug: Rapamycin
40 Completed
Has Results
New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Mycophenolate mofeteil (MMF);   Drug: Daclizumab (DZB);   Drug: Placebo control for Mycophenolate mofeteil (MMF);   Drug: Placebo control for Daclizumab (DZB)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.